FDA finalized historic rule enabling access to Over-the-Counter hearing aids for millions of Americans
On Oct. 19, 2022, the U.S. Food and Drug Administration final rule establishing Over-the-Counter Hearing Aids to improve…
U.S. FDA recommended Novavax COVID-19 vaccine, adjuvanted as a booster in adults
On Oct. 19, 2022, the U.S. FDA recommended the use of the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) as…
EMA’s CHMP for Human Use issued positive opinion recommending authorization for use of Spikevax in children 6 months – 5 years in EU
On Oct. 19, 2022, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
90-Day analysis showed Moderna’s Omicron BA.1-targeting bivalent vaccine, mRNA-1273.214, demonstrated superior antibody response as fourth booster Compared to Spikevax Prototype Booster
On Oct. 19, 2022, Moderna announced new clinical data on its bivalent Omicron-containing booster, mRNA-1273.214. Ninety days after…
Pfizer and BioNTech received positive CHMP ppinion for COMIRNATYï¾® in children 6 months to less than 5 lears in EU
On Oct. 19, 2022, Pfizer and BioNTech announced that the European Medicines Agencyï¾’s (EMA) Committee for Medicinal Products…
Global leaders committed US$ 2.6 billion at World Health Summit to end polio
On Oct. 18, 2022, global leaders confirmed US$ 2.6 billion in funding toward the Global Polio Eradication Initiativeï¾’s…
Moderna announced supply agreement with Gavi that secured access to updated variant-specific COVID-19 vaccines for low-and-middle income countries
On Oct. 17, 2022, Moderna and Gavi, the Vaccine Alliance, have mutually agreed to cancel remaining pending orders…
DNA evidence of plague found in Central Asia
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
Novavax COVID-19-influenza combination vaccine candidate induced antibody and T-Cell responses against SARS-CoV-2 and influenza
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
Pfizer and BioNTech announced positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
Honeycrisp apple genome was completed
On Oct. 13, 2022, a team of researchers led by Cornell University announced they had sequenced the Honeycrisp…
Gene associated with better immune response and protection after COVID-19 vaccination identified by Oxford researchers
On Oct. 13, 2022, researchers from the University of Oxford reported findings from a study exploring how certain…
Chinese medical writings recorded decreases in goiter size upon ingestion of seaweed (iodine)
Early Chinese medical writings in approximately 3600 B.C. were the first to record the decreases in goiter size…
Hutchinson Cancer Center announced $710.5 million gift to support cancer and infectious disease research, ﾑskin-on-chipﾒ technology
On Oct. 12, 2022, the Fred Hutchinson Cancer Center announced the Bezos family had committed $710.5 million over…
Moderna received Authorization for Emergency Use from FDA of Omicron-targeting bivalent COVID-19 booster vaccine for children
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
Biotechnology | CDC | COVID-19 | FDA | Life Science News
Pfizer and BioNTech received U.S. FDA EUA for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster in children
On Oct. 12, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration granted Emergency Use…
Researchers developed method to study brain connectivity, functionality
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
Roche launched next-generation portfolio of SARS-CoV-2 rapid antigen tests
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (ﾓ2.0ï¾”) for…
Intranasal COVID-19 vaccine candidateï¾’s clinical data highlighted need for further development of nasal spray vaccines
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
Novavax and SK bioscience filed post approval change application in South Korea for Nuvaxovidï¾™ COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
Switzerland’s Federal Office of Public Health recommended Novavax Nuvaxovid COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that Switzerlands Federal Office of Public Health had recommended Nuvaxovidï¾™(NVX-CoV2373) as a…
Mayo Clinic received $100 million gift from Fred C. and Katherine B. Andersen Foundation to expand proton beam therapy services
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
FDA approved vaccine for use during third trimester of pregnancy to prevent whooping cough in infants
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
FDA authorized Monkeypox test
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster received Health Canada authorization for individuals 12 years of age and older
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada has authorized COMIRNATY Original & Omicron BA.4/BA.5…
3D map revealed DNA organization within human retina cells
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
USDA confirmed highly pathogenic Avian influenza in commercial chickens in Arkansas
On Oct. 7, 2022, the U.S. Department of Agricultureï¾’s Animal Plant Health Inspection Service confirmed the presence of…
Japanese vaccine database Created to assess Vaccine Effectiveness and adverse events
On Oct. 6, 2022, researchers in Japan released a study that described the development and application of the…
Merck and Ridgeback Biotherapeutics provided update on new clinical and non-clinical studies of LAGEVRIOï¾™ (molnupiravir)
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOï¾™ (molnupiravir), an investigational oral…
WHO warned of deadly cholera outbreak in Lebanon as cases increase
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…